News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
693,328 Results
Type
Article (39416)
Company Profile (249)
Press Release (653663)
Section
Business (204043)
Career Advice (2006)
Deals (35408)
Drug Delivery (93)
Drug Development (80956)
Employer Resources (169)
FDA (16137)
Job Trends (14831)
News (344911)
Policy (32478)
Tag
Academia (2536)
Alliances (49327)
Alzheimer's disease (1316)
Approvals (16124)
Artificial intelligence (208)
Bankruptcy (357)
Best Places to Work (11637)
Biotechnology (177)
Breast cancer (230)
Cancer (1760)
Cardiovascular disease (132)
Career advice (1670)
CAR-T (127)
Cell therapy (366)
Clinical research (65324)
Collaboration (685)
Compensation (376)
COVID-19 (2568)
C-suite (171)
Data (1674)
Diabetes (218)
Diagnostics (6298)
Earnings (85630)
Employer resources (145)
Events (111079)
Executive appointments (583)
FDA (17072)
Funding (616)
Gene therapy (251)
GLP-1 (656)
Government (4362)
Healthcare (18782)
Infectious disease (2684)
Interviews (311)
IPO (16466)
Job creations (3627)
Job search strategy (1421)
Layoffs (440)
Legal (7890)
Lung cancer (258)
Manufacturing (241)
Medical device (13271)
Medtech (13276)
Mergers & acquisitions (19329)
Metabolic disorders (565)
Neuroscience (1731)
NextGen: Class of 2025 (6509)
Non-profit (4476)
Northern California (2162)
Obesity (311)
Opinion (196)
Patents (173)
People (56887)
Phase I (20342)
Phase II (28776)
Phase III (21423)
Pipeline (769)
Postmarket research (2562)
Preclinical (8585)
Radiopharmaceuticals (242)
Rare diseases (328)
Real estate (5897)
Regulatory (21955)
Research institute (2314)
Resumes & cover letters (349)
Southern California (1857)
Startups (3569)
United States (19051)
Vaccines (617)
Weight loss (212)
Date
Last 7 days (799)
Last 30 days (2577)
Last 365 days (34229)
2025 (5225)
2024 (35219)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (717)
Arizona (211)
Asia (37539)
Australia (6136)
California (4932)
Canada (1745)
China (407)
Colorado (225)
Connecticut (234)
Europe (80476)
Florida (727)
Georgia (171)
Illinois (461)
Indiana (268)
Japan (125)
Maryland (756)
Massachusetts (3755)
Michigan (200)
Minnesota (341)
New Jersey (1394)
New York (1415)
North Carolina (851)
Northern California (2162)
Ohio (174)
Pennsylvania (1127)
South America (1093)
Southern California (1857)
Texas (723)
Utah (152)
Washington State (474)
693,328 Results for "lensar inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
LENSAR Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update
February 28, 2025
·
19 min read
Press Releases
LENSAR to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 27, 2025
February 19, 2025
·
1 min read
Deals
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR’s board of directors granted three newly-hired non-executive employees stock options to purchase an aggregate of 2,150 shares of the Company’s common stock.
June 3, 2024
·
1 min read
Press Releases
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 3, 2025
February 4, 2025
·
1 min read
BioMidwest
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 01, 2024
LENSAR, Inc. announced that a majority of the independent members of LENSAR’s board of directors granted two newly-hired non-executive employees stock options to purchase an aggregate of 875 shares of the Company’s common stock.
May 1, 2024
·
1 min read
Business
LENSAR Reports First Quarter 2024 Results and Provides Business Update
LENSAR, Inc. today announced financial results for the quarter ended March 31, 2024 and provided an update on key operational initiatives.
May 9, 2024
·
13 min read
LENSAR to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference
LENSAR, Inc. today announced that Nick Curtis, Chief Executive Officer, will participate in a Fireside Chat at the 2024 Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024, at 1:40 p.m. CT in Austin, TX.
May 23, 2024
·
1 min read
BioMidwest
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 01, 2024
LENSAR, Inc. announced that a majority of the independent members of LENSAR’s board of directors granted three newly-hired non-executive employees stock options to purchase an aggregate of 1,425 shares of the Company’s common stock.
April 1, 2024
·
1 min read
Business
LENSAR to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
LENSAR, Inc. today announced that the Company’s first quarter 2024 financial results will be released before market open on Thursday, May 9, 2024.
May 2, 2024
·
1 min read
BioMidwest
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 01, 2024
LENSAR, Inc. announced that a majority of the independent members of LENSAR’s board of directors granted seven newly-hired non-executive employees stock options to purchase an aggregate of 4,175 shares of the Company’s common stock.
March 1, 2024
·
1 min read
1 of 69,333
Next
